Advertisement
OtherArticle

The glycosylated N-terminal domain of MUC1 is involved in chemoresistance by modulating drug permeation across the plasma membrane

Kaori Miyazaki, Hisanao Kishimoto, Hanai Kobayashi, Ayaka Suzuki, Kei Higuchi, Yoshiyuki Shirasaka and Katsuhisa Inoue
Molecular Pharmacology December 5, 2022, MOLPHARM-AR-2022-000597; DOI: https://doi.org/10.1124/molpharm.122.000597
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherArticle

Extracellular domain of MUC1 prevents drug permeation

Kaori Miyazaki, Hisanao Kishimoto, Hanai Kobayashi, Ayaka Suzuki, Kei Higuchi, Yoshiyuki Shirasaka and Katsuhisa Inoue
Molecular Pharmacology December 5, 2022, MOLPHARM-AR-2022-000597; DOI: https://doi.org/10.1124/molpharm.122.000597
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

Jump to section

Advertisement